Literature DB >> 7780036

In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary by-pass.

A Naldini1, E Borrelli, S Cesari, P Giomarelli, M Toscano.   

Abstract

Cardiac surgery, employing cardiopulmonary by-pass (CPB), has long been associated with a generalized immunosuppression. To further understand the complex physiological and immunological changes related to CPB, we decided to investigate whether CPB affects the immune response, with regard to T-cell activation and cytokine production. Using phytohaemagglutinin (PHA) as mitogen and peripheral blood mononuclear cells (PBMC) isolated from patients undergoing CPB, we investigated whether this procedure has any effect on interferon-gamma(IFN-gamma) and other cytokine production and/or PBMC proliferation. Comparisons were made between the responsiveness of PBMC obtained before, during and at the end of CPB. In all patients, CPB significantly reduces IFN-gamma and interleukin 2 (IL-2) production in response to PHA. On the other hand, tumour necrosis factor-alpha (TNF-alpha) production was also significantly diminished, while interleukin 6 (IL-6), interleukin 1 beta (IL-1 beta) and interleukin 8 (IL-8) release in response to PHA was not significantly affected. Reduced IFN-gamma, IL-2 and TNF-alpha production was associated with a significant decrease in PBMC proliferation. These results might be related to the mechanical damage on blood cells described during extracorporeal circulation procedures as well as the release of immunosuppressive factors during surgery. The immunosuppression observed during CPB may play an important role in the development of infectious complications after CPB.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780036     DOI: 10.1006/cyto.1995.1022

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

1.  The effects of extracorporeal whole body hyperthermia on the functional and phenotypic features of canine peripheral blood mononuclear cells (PBMC).

Authors:  R J Kearns; S Ringler; S Krakowka; R Tallman; J Sites; M J Oglesbee
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 2.  Lung inflammatory response syndrome after cardiac-operations and treatment of lornoxicam.

Authors:  Kosmas Tsakiridis; Andreas Mpakas; George Kesisis; Stamatis Arikas; Michael Argyriou; Stavros Siminelakis; Paul Zarogoulidis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Theodora Tsiouda; Eirini Sarika; Ioanna Katamoutou; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

Review 3.  Off-pump coronary artery bypass surgery in patients with coronary artery disease and malign neoplasia: results of ten patients and review of the literature.

Authors:  Ibrahim Ozsöyler; Levent Yilik; Sahin Bozok; Bilgin Emrecan; Mert Kestelli; Nagihan Karahan; Ali Gürbüz
Journal:  Heart Vessels       Date:  2006-11-27       Impact factor: 2.037

4.  Comparison of the effects of desflurane and propofol anesthesia on the inflammatory response and s100β protein during coronary artery bypass grafting.

Authors:  Elif Doğan Baki; Mustafa Aldemir; Serdar Kokulu; Halit Buğra Koca; Yüksel Ela; Remziye Gül Sıvacı; Nilgün Kavrut Öztürk; Mustafa Emmiler; Fahri Adalı; Hanife Uzel
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

5.  Flow cytometric evaluation of T cell activation markers after cardiopulmonary bypass.

Authors:  Maja-Theresa Dieterlen; Hartmuth B Bittner; Attila Tarnok; Jens Garbade; Stefan Dhein; Friedrich W Mohr; Markus J Barten
Journal:  Surg Res Pract       Date:  2014-02-06

6.  Plasma levels of immunosuppressive mediators during cardiopulmonary bypass.

Authors:  E Borrelli; P Giomarelli; A Naldini; E Luzzi; S Silvestri; M Gardinali; V Bocci
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

7.  Effects of perioperative transcutaneous electrical acupoint stimulation on monocytic HLA-DR expression in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass: study protocol for a double-blind randomized controlled trial.

Authors:  Wen-Ting Chen; Jin-Feng Wei; Lan Wang; Deng-Wen Zhang; Wei Tang; Jian Wang; Yue Yong; Jing Wang; Ya-Lan Zhou; Lan Yuan; Guo-Qiang Fu; Sheng Wang; Jian-Gang Song
Journal:  Trials       Date:  2019-12-30       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.